Vivo Capital’s Insmed INSM Stock Holding History

Vivo Capital’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-1,748,174	Closed	-$44.8M	–	17
2019 Q2	$44.8M	Buy	1,748,174 +577,884	+49%	+$16.1M	4.19%	6
2019 Q1	$34M	Buy	+1,170,290	New	+$30.3M	3.39%	7

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Vivo Capital's INSM Position: Q3 2019 in Review

Vivo Capital sold out of Insmed (INSM) in Q3 2019, closing a stake of 1,748,174 shares — an estimated $44.8M sold.

Vivo Capital first reported a position in INSM in Q1 2019 and held it in 2 quarters. The position peaked at $44.8M in Q2 2019. 157 funds tracked by Wall St. Rank hold INSM as of Q3 2019.

Vivo Capital reported no remaining Insmed position as of Q3 2019 after selling out during the quarter.
Vivo Capital sold 1,748,174 Insmed shares in Q3 2019, an estimated $44.8M.
Vivo Capital first reported a position in Insmed in Q1 2019 and held it in 2 quarters.
Vivo Capital's Insmed position peaked at $44.8M in Q2 2019.
157 funds tracked by Wall St. Rank held Insmed as of Q3 2019.

Based on Vivo Capital's 13F filing for Q3 2019, filed 13 Nov 2019.